Form D · Biotechnology
Allarity Therapeutics, Inc.
Boston, MA · CIK 0001860657
Offering snapshot reported Feb 2, 2024 · SEC filing
- Reported sold
- $400K Offering amount: $1.4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 18, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 2, 2024 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Sep 21, 2023 | Initial | $1,601,578 | No comparison | 2 | SEC filing |
| Apr 28, 2023 | Initial | $350,000 | No comparison | 1 | SEC filing |
| Apr 28, 2023 | Initial | $3,366,640 | No comparison | 1 | SEC filing |
| Mar 1, 2023 | Initial | $1,200,000 | No comparison | 1 | SEC filing |
| May 27, 2021 | Initial | $20,000,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-504322
$400,000 represents the subscription amount of senior promissory note issued and sold to 1 accredited institutional investor, pursuant to a securities purchase agreement, dated January 18, 2024.
Senior Convertible Promissory Notes
Source: Form D, filed Feb 2, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laura Benjamin | Director |
| Joan Brown | Executive |
| Steve Carchedi | Director, Executive |
| James Cullem | Director, Executive |
| Marie Foegh | Executive |
| Thomas Jensen | Director, Executive |
| Steen Knudsen | Executive |
| Jens Erik Knudsen | Executive |
| Gerald Mc Laughlin | Director |
| David A. Roth | Director |
| Joseph Vazzano | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
24 School St., 2 Nd Floor
Boston, MA, 02108
Boston, MA, 02108